Description:The peptide is used to block Anti-CD66a/b/c Antibody (#CPA6021) reactivity.Form:Lyophilized powderGene Symbol:CEACAM1; CEACAM6; CEACAM8Alternative Names:CEACAM1; BGP; BGP1; Carcinoembryonic antigen-related cell adhesion molecule 1; Biliary glycoprotein 1; BGP-1; CD66a; CEACAM6; NCA; Carcinoembryonic antigen-related cell adhesion molecule 6; Non-specific crossreacting antigen; Normal cross-reacting antigen; CD66c; CEACAM8; CGM6; Carcinoembryonic antigen-related cell adhesion molecule 8; CD67 antigen; Carcinoembryonic antigen CGM6; Non-specific cross-reacting antigen NCA-95; CD66b
Entrez Gene (Human):
634;
4680;
1088;
SwissProt (Human):
P13688;
P40199;
P31997;
Purity:>85%Directions for Use:Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control:The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability:Shipped at 4°C. Store at -20°C for one year.